Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-glaxosmithkline.jpg" NAME"Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options" ALT"Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options"May…